FI950010A - Bradykiniiniantagonistien käyttö lääkeaineiden valmistamiseksi virussairauksien hoitamiseksi - Google Patents

Bradykiniiniantagonistien käyttö lääkeaineiden valmistamiseksi virussairauksien hoitamiseksi Download PDF

Info

Publication number
FI950010A
FI950010A FI950010A FI950010A FI950010A FI 950010 A FI950010 A FI 950010A FI 950010 A FI950010 A FI 950010A FI 950010 A FI950010 A FI 950010A FI 950010 A FI950010 A FI 950010A
Authority
FI
Finland
Prior art keywords
treatment
medicaments
manufacture
viral diseases
bradykinin antagonists
Prior art date
Application number
FI950010A
Other languages
English (en)
Swedish (sv)
Other versions
FI950010A0 (fi
FI117320B (fi
Inventor
Klaus Wirth
Irvin Winkler
Fred Lembeck
Gerhard Breipohl
Stephan Henke
Jochen Knolle
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI950010A0 publication Critical patent/FI950010A0/fi
Publication of FI950010A publication Critical patent/FI950010A/fi
Application granted granted Critical
Publication of FI117320B publication Critical patent/FI117320B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043Kallidins; Bradykinins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/18Kallidins; Bradykinins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI950010A 1993-12-31 1995-01-02 Bradykiniiniantagonistien käyttö lääkeaineiden valmistamiseksi virussairauksien hoitamiseksi FI117320B (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4345062A DE4345062A1 (de) 1993-12-31 1993-12-31 Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen

Publications (3)

Publication Number Publication Date
FI950010A0 FI950010A0 (fi) 1995-01-02
FI950010A true FI950010A (fi) 1995-07-01
FI117320B FI117320B (fi) 2006-09-15

Family

ID=6506576

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950010A FI117320B (fi) 1993-12-31 1995-01-02 Bradykiniiniantagonistien käyttö lääkeaineiden valmistamiseksi virussairauksien hoitamiseksi

Country Status (21)

Country Link
US (1) US5789383A (fi)
EP (1) EP0661058B1 (fi)
JP (1) JP3828593B2 (fi)
KR (1) KR100358822B1 (fi)
CN (1) CN1119171C (fi)
AT (1) ATE255417T1 (fi)
AU (1) AU696629B2 (fi)
BR (1) BR9405308A (fi)
CA (1) CA2138933C (fi)
DE (2) DE4345062A1 (fi)
DK (1) DK0661058T3 (fi)
ES (1) ES2211874T3 (fi)
FI (1) FI117320B (fi)
HU (1) HU226374B1 (fi)
IL (1) IL112183A (fi)
MY (1) MY112888A (fi)
NO (1) NO317660B1 (fi)
PT (1) PT661058E (fi)
RU (1) RU2228195C2 (fi)
UA (1) UA41326C2 (fi)
ZA (1) ZA9410381B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737408B1 (fr) * 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
WO2016170382A1 (en) * 2015-04-23 2016-10-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Pharmaceutical compositions comprising a bradykinin 2 receptor antagonist for prevention or treatment of impaired skin wound healing
RS63143B1 (sr) 2016-06-01 2022-05-31 Athira Pharma Inc Jedinjenja

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
JPH06508116A (ja) * 1991-04-01 1994-09-14 コルテク,インコーポレイテッド ブラジキニンアンタゴニスト
AU1873992A (en) * 1991-04-19 1992-11-17 Nova Technology Limited Partnership Bradykinin antagonist peptides
CA2106768C (en) * 1991-04-19 2000-09-19 Donald J. Kyle Bradykinin type peptides
US5240694A (en) * 1991-09-23 1993-08-31 University Of Virginia Combined antiviral and antimediator treatment of common colds
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds

Also Published As

Publication number Publication date
UA41326C2 (uk) 2001-09-17
EP0661058B1 (de) 2003-12-03
JP3828593B2 (ja) 2006-10-04
HU9403783D0 (en) 1995-02-28
FI950010A0 (fi) 1995-01-02
JPH07206703A (ja) 1995-08-08
NO317660B1 (no) 2004-11-29
NO945094D0 (no) 1994-12-30
NO945094L (no) 1995-07-03
EP0661058A1 (de) 1995-07-05
RU2228195C2 (ru) 2004-05-10
CA2138933A1 (en) 1995-07-01
RU94045140A (ru) 1996-10-20
HUT71422A (en) 1995-11-28
KR100358822B1 (ko) 2003-01-24
IL112183A (en) 2001-01-11
US5789383A (en) 1998-08-04
ZA9410381B (en) 1995-08-29
PT661058E (pt) 2004-04-30
CA2138933C (en) 2010-02-23
HU226374B1 (en) 2008-10-28
BR9405308A (pt) 1995-09-19
AU8179194A (en) 1995-07-13
IL112183A0 (en) 1995-03-15
MY112888A (en) 2001-10-31
ATE255417T1 (de) 2003-12-15
CN1119171C (zh) 2003-08-27
DE4345062A1 (de) 1995-07-13
DK0661058T3 (da) 2004-04-05
DE59410340D1 (de) 2004-01-15
ES2211874T3 (es) 2004-07-16
AU696629B2 (en) 1998-09-17
KR950016779A (ko) 1995-07-20
CN1108138A (zh) 1995-09-13
FI117320B (fi) 2006-09-15

Similar Documents

Publication Publication Date Title
FI862011A0 (fi) Terapeutiska nukleosider.
KR900009625A (ko) 피리미딘류 및 그의 약리학적으로 허용되는 염류 및 그 용도
NO933077L (no) Anvendelse av IL-4-reseptor for terapi i profylakse og diagnostikk av allergiske, virale og parasitiske og bakterielle sykdommer
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
DE69232323D1 (de) Verwendung von Adenosinantagonisten zur Vorbeugung und Behandlung von Pankreatitis und Ulcera
DK678887A (da) Farmaceutiske praeparater
ITBO920277A1 (it) Endoprotesi per osteosintesi del femore prossimale
NO914986D0 (no) Fremgangsmaate for fremstilling av anti-herpescastanosperminestere
FI950010A0 (fi) Bradykiniiniantagonistien käyttö lääkeaineiden valmistamiseksi virussairauksien hoitamiseksi
DK347289D0 (da) Terapeutiske forbindelser
DE69419954D1 (de) Arzneimittel zur Behandlung von Hauterkrankungen
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
EP0454429A3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
ES2037807T3 (es) Medicamentos que contienen en combinacion interferon y 1-desoxi-piperidinosas, procedimiento para su fabricacion y su aplicacion.
ES2093138T3 (es) El empleo de 1-(5-oxohexil)-3-metil-7-n-propil-xantina en cirugia vascular.
DK0836853T3 (da) Anvendelse af bradykinin-antagonister til fremstilling af lægemidler til behandling og forebyggelse af Alzheimers sygdom
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
DK0495721T3 (da) Anvendelsen af et polypeptid med en humant-interleukin-2-aktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af pneumothorax
SE8702227D0 (sv) New use
IT224936Z2 (it) Presidio chirurgico radiotrasparente per il trattamento di patologie e traumi ortopedici.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117320

Country of ref document: FI

MA Patent expired